Similar to BCR-ABL1 positive ALL, patients with BCR-ABL-like ALL have reduced five-year disease-free survival of 59.5% versus 84.4% for patients with other precursor B-ALL [38]. Here, ABL1 is linked to acute lymphoblastic leukemia.